MCHR1 and depressive symptom measurement: Meanwhile, we further discovered that the activation of MCH in the LC by CUS and acute microinjection of MCH produced depression-like behaviors by downregulating NE production, which was reversed by the MCHR1 antagonist SNAP-94847.